Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Seow

Showing results (21-30 of 47) with videos related to

Pageof 5
Sort By:
Cell Reports. Medicine|February 3, 2026
Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infectionsLuke B Snell, Suzanne Pickering, Adela Alcolea-Medina, et al.
Journal of Medical Virology|July 21, 2022
Concordance of B- and T-cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19Marc F Österdahl, Eleni Christakou, Deborah Hart, et al.
Plos Pathogens|October 3, 2022
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concernCarl Graham, Thomas Lechmere, Aisha Rehman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2019
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apexVictoria A Avanzato, Kasopefoluwa Y Oguntuyo, Marina Escalera-Zamudio, et al.
Journal of Molecular Biology|February 13, 2017
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2Jeffrey Seow, Rodrigo A V Morales, Christopher A MacRaild, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Cell Reports|April 27, 2022
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variantsJeffrey Seow, Carl Graham, Sadie R Hallett, et al.
British Journal of Haematology|June 4, 2021
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemiaPatrick Harrington, Katie J Doores, Deepti Radia, et al.
Cell Reports|March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralizationChloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Plos One|April 7, 2021
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic waveNicola Sweeney, Blair Merrick, Rui Pedro Galão, et al.
Pageof 5

Showing results (21-30 of 47) with videos related to

Sort By:
Pageof 5
Cell Reports. Medicine|February 3, 2026
Antibody escape drives emergence of diverse spike haplotypes resembling variants of concern in persistent SARS-CoV-2 infectionsLuke B Snell, Suzanne Pickering, Adela Alcolea-Medina, et al.
Journal of Medical Virology|July 21, 2022
Concordance of B- and T-cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19Marc F Österdahl, Eleni Christakou, Deborah Hart, et al.
Plos Pathogens|October 3, 2022
The effect of Omicron breakthrough infection and extended BNT162b2 booster dosing on neutralization breadth against SARS-CoV-2 variants of concernCarl Graham, Thomas Lechmere, Aisha Rehman, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 27, 2019
A structural basis for antibody-mediated neutralization of Nipah virus reveals a site of vulnerability at the fusion glycoprotein apexVictoria A Avanzato, Kasopefoluwa Y Oguntuyo, Marina Escalera-Zamudio, et al.
Journal of Molecular Biology|February 13, 2017
Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2Jeffrey Seow, Rodrigo A V Morales, Christopher A MacRaild, et al.
Nature Communications|December 31, 2024
Antibodies to the RBD of SARS-CoV-2 spike mediate productive infection of primary human macrophagesSuzanne Pickering, Harry Wilson, Enrico Bravo, et al.
Cell Reports|April 27, 2022
ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variantsJeffrey Seow, Carl Graham, Sadie R Hallett, et al.
British Journal of Haematology|June 4, 2021
Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) induces neutralising antibody and polyfunctional T-cell responses in patients with chronic myeloid leukaemiaPatrick Harrington, Katie J Doores, Deepti Radia, et al.
Cell Reports|March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralizationChloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Plos One|April 7, 2021
Clinical utility of targeted SARS-CoV-2 serology testing to aid the diagnosis and management of suspected missed, late or post-COVID-19 infection syndromes: Results from a pilot service implemented during the first pandemic waveNicola Sweeney, Blair Merrick, Rui Pedro Galão, et al.
Pageof 5